# James Marsh Chief Executive Officer ## Career chronology - **15 years before subsequent roles: Imerys Minerals Limited** — Technical Manager / global kaolin calcination team. [Executive Leadership Significantly Strengthened]() (pp. 1–2, appointment release, Imerys experience and technical responsibilities) - **30 May 2018 to 1 April 2023: Andromeda Metals Limited** — Managing Director/CEO, then Executive Director – Sales & Marketing. [Annual Report 2023]() (p. 49, directors report biography and role transition) - **From 9 September 2024: Zeotech Limited** — Chief Executive Officer. [Annual Report 2025]() (p. 24, Marsh service agreement) ## Education and qualifications ### Education and professional qualification [zeo_james_marsh_education] As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality The issuer reports a BSc (Honours) from the University of the West of England; Andromeda’s 2023 annual report also identifies BSc (Hons) and MAusIMM. Credential verification remains outside these public-source checks. **Attribution:** Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained. **Relevance:** Relevant to role-fit assessment and subject to verification gap. [Our People]() (Our People, James Marsh biography, lines 5–8) ## Contributions and company outcomes ### FY2026 project and commercial milestones [zeo_james_marsh_fy26_delivery] FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate CEO's personal contribution or establish booked DSO/AusPozz sales. **Attribution:** Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented. **Relevance:** Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue. [Annual Report to shareholders]() (FY2026 annual report, CEO/operating report); [Quarterly Activities and Appendix 5B Cash Flow Report]() (pp. 1–8, activities report) ### Kaolin development leadership at Andromeda; project remained pre-production [zeo_james_marsh_andromeda_role] 2018-05-30 to 2023-03-31 · issuer reported · medium materiality Andromeda’s 2023 annual report records Marsh as Managing Director from 30 May 2018 to 31 March 2023, followed by Executive Director – Sales & Marketing. Its Great White Project reached a 2023 DFS stage with a 15.1 Mt reserve and construction-ready permits, but funding and investment decision remained prerequisites to development. The report does not quantify Marsh’s personal contribution; these are employer outcomes during his role. **Attribution:** Role overlaps event; causation unproven. Marsh held senior executive responsibilities; the company report does not establish individual causal contribution to the DFS, reserve or permits. **Relevance:** Relevant industrial-minerals experience with an execution caveat: study/permit milestones did not equal producing operations during his tenure. [Annual Report 2023]() (pp. 15–17 project readiness; p. 49 appointment and role chronology; p. 83 funding caveat) ## Business failures and setbacks ### Pre-commercial status and funding dependence [zeo_james_marsh_fy26_funding] FY2026 to 2026-06-30 · issuer reported · medium materiality FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility. **Attribution:** Role overlaps event; causation unproven. The CEO role overlapped the reported period; no personal causal attribution is established. **Relevance:** Material to assessing delivery and capital allocation for a development-stage company. [Annual Report to shareholders]() (FY2026 annual report, financial statements and going-concern funding risk) ## Suitability for the current role ### Role relevance and evidenced background [zeo_james_marsh_fit] Background reviewed through 2026-10-09 · analyst inference · low materiality The issuer reports 30+ years in industrial minerals and advanced materials, 15 years at Imerys and a BSc (Honours) from the University of the West of England. Current title in the selected roster: Chief Executive Officer. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes. **Attribution:** Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made. **Relevance:** Relevant to the current Chief Executive Officer responsibilities, subject to the evidence limitations recorded below. [Our People]() (Executive biography or corporate-directory entry for the named person) ## Evidence gaps - Detailed exact dates for Imerys, Minerals Corporation and Active Minerals roles and complete concurrent board interests are not independently verified. - Andromeda outcomes were company-level; personal causal contribution and subsequent appellate/legal outcomes were not established. - No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.